In a study conducted by Malicki et al. [24], the effects of simvastatin on the secretion levels of two pro-inflammatory cytokines, IL-6 and IL-8, were assessed in CRC tumor tissue and adjacent healthy margins, as well as in vitro using the HT-29 and Caco-2 cell lines [24]. Here, IL6 is linked to neoplasm.